Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C055382
http://purl.bioontology.org/ontology/MESH/C055382
|
|---|---|
| Preferred Name | naltrindole |
| Synonyms |
4,8-Methanobenzofuro(2,3-a)pyrido(4,3-b)carbazole-1,8a(9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-, (8R-(4bS*,8alpha,8abeta,14bbeta))-
17-cyclopropylmethyl-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7,2',3'-indolomorphinan
natrindole hydrochloride
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | 4,8-Methanobenzofuro(2,3-a)pyrido(4,3-b)carbazole-1,8a(9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-, (8R-(4bS*,8alpha,8abeta,14bbeta))-
17-cyclopropylmethyl-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7,2',3'-indolomorphinan
natrindole hydrochloride
|
|---|---|
| prefLabel | naltrindole
|
| Scope Statement | delta opioid receptor antagonist
|
| type | |
| isa | |
| PA | D009292
|
| tui |
T109
T121
|
| Has mapping qualifier | |
| HM | D009271/Q000031
|
| SC | 1
|
| TERMUI |
T185947
T679389
T185946
|
| TH |
FDA SRS (2017)
INN (19XX)
NLM (2006)
NLM (1988)
|
| SRC | Eur J Pharmacol 1988;146(1):185
|
| MMR | 20160818
|
| notation | C055382
|
| Semantic type UMLS property | |
| RR | 111555-53-4 (naltrindole)
|
| cui |
C0068389
C0090724
C1737978
|
| MeSH Frequency | 736
|
| PI |
*MORPHINANS (88-93)
*INDOLES (88-93)
|
| DSC | 19880502
|
| Inverse of RB | G167Z38QA4
|
| Mapped to | |
| MDA | 19880502
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |